Quality of life and late toxicity after total neoadjuvant treatment for locally advanced rectal cancer – LARCT-US
An abbreviated TNT schedule, compared with the RAPIDO-study, used in LARCT-US, achieves favourable oncological outcomes with low risk of late toxicity, and an acceptable QoL similar to other less effective neoadjuvant treatments.
Authors
- Per J. Nilsson (ORCID: https://orcid.org/0000-0003-0438-5887)
- Israa Imam (ORCID: https://orcid.org/0000-0002-0232-2391)
- Bengt Glimelius
- Tanweera Khan (ORCID: https://orcid.org/0000-0003-0679-9450)
Institutions
- Karolinska University Hospital (SE)
- Uppsala University Hospital (SE)
Publication Details
- Journal
- Radiotherapy and Oncology
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1016/j.radonc.2025.111318
- Citations
- 3
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.14